| 5L2S: reference: Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance., Chen P, Lee N, Hu W, Xu M, Ferre RA, Lam H, Bergqvist S, Solowiej J, Diehl W, He YA, Yu X, Nagata A, VanArsdale T, Murray BW, Mol Cancer Ther. 2016 Aug 5. pii: molcanther.0300.2016. PMID: 27496135 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).